产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 5mg | 99% | 询价 | |||
| 10mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 |
CAS No. |
903565-83-3 |
|---|---|
中文名称 |
(1S,3'R,4'S,5'S,6'R)-6-[(4-乙基苯基)甲基]-6'-(羟甲基)-3',4',5',6'-四氢-3H-螺[异苯并呋喃-1,2'-吡喃]-3',4',5'-三醇 |
英文名称 |
(1S,3'R,4'S,5'S,6'R)-6-(4-Ethylbenzyl)-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3H-spiro[isobenzofuran-1,2'-pyran]-3',4',5'-triol |
别名 |
DTXSID90238097 | R-7201 | GTPL9395 | RO4998452 | RO-4998452 | AC-31468 | C6H18N3OP | NCGC00485920-01 | CSG 452 | deberza | compound 16d [PMID: 22889351] | NCGC00257160-01 | Tofogliflozin [INN] | A836961 | BDBM50396779 | Tofogliflozin anhydrous | UNII-5542 |
标准英文名 |
(1S,3'R,4'S,5'S,6'R)-6-(4-ethylbenzyl)-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3H-spiro[isobenzofuran-1,2'-pyran]-3',4',5'-triol |
分子式 |
C22H26O6 |
分子量 |
386.44 |
精确分子量 |
386.17 |
SMILES |
O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@]21OCC3=C2C=C(CC4=CC=C(CC)C=C4)C=C3 |
标准SMILES |
CCC1=CC=C(CC2C=CC3CO[C@]4(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C=3C=2)C=C1 |
性状 |
No data available |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
VWVKUNOPTJGDOB-BDHVOXNPSA-N |
危险类别(旧) |
H302 |
存储要求 |
Sealed in dry, Room Temperature,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral,Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory system (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|